Dr. Novack provided an update on novel therapies in pharmacotherapies in Ophthalmology Times. He reviews treatments in all phases of clinical development, and those recently approved. This is from anterior (dry eye, glaucoma) to posterior (wet AMD, etc).
- Ophthalmic Drug Delivery – Dr. Novack quoted in EyeWorld
- Dr. Gary Novack receives ARVO Drug Development Award
- University of California, Davis School of Veterinary Medicine Ophthalmology Grand Rounds
- Sonoma Eye 2018 – Foster Ophthalmic Immunology Society
- UC Davis Library Leadership Board
- FDA Commissioner cites “Kabuki drug-pricing constraints”